Document Detail


Bipyridine derivatives lower arteriolar resistance and improve left ventricular function in newborn lambs.
MedLine Citation:
PMID:  3684374     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Milrinone may be used in the treatment of pulmonary hypertensive diseases of the newborn. We have studied its effects in chronically instrumented newborn lambs over a dose range from 1-100 micrograms/kg. These actions have been compared with those of amrinone. We have also tested the effect of milrinone on hypoxia and leukotriene D4-induced pulmonary vasoconstriction. Injected into the right pulmonary artery, both amrinone and milrinone cause a dose-related fall in pulmonary arteriolar resistance with milrinone being approximately 20 times more potent than amrinone and possessing an ED50 of about 10 micrograms/kg. Both agents increase left ventricular dp/dt significantly and tend to increase cardiac output. Systemic vascular resistance falls with both drugs but the change is significant only with milrinone. While milrinone attenuates the increase in pulmonary arteriolar resistance induced by leukotriene D4 and hypoxia, this is probably an indirect effect. Milrinone does not modify either the increases in left atrial, aortic pressure, and systemic vascular resistance or the decreases in cardiac output and left ventricular dp/dt induced by leukotriene D4. These findings suggest that milrinone deserves clinical trial in newborn infants with pulmonary hypertension in whom myocardial depression often coexists.
Authors:
J Y Coe; P M Olley; G Vella; F Coceani
Related Documents :
19537834 - Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances...
1191434 - Pulmonary valve echo motion in pulmonary regurgitation.
11157624 - Nitric oxide and molsidomine in the management of pulmonary hypertension in takayasu's ...
6108164 - An analysis of the pulsatile hemodynamic responses of the pulmonary circulation to acut...
9423714 - Femorocaval bypass with femoral crossover bypass for iliofemoral and caval occlusion.
16720244 - [11c]palmitate kinetics across the splanchnic bed in arterial, portal and hepatic venou...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Pediatric research     Volume:  22     ISSN:  0031-3998     ISO Abbreviation:  Pediatr. Res.     Publication Date:  1987 Oct 
Date Detail:
Created Date:  1987-12-30     Completed Date:  1987-12-30     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0100714     Medline TA:  Pediatr Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  422-8     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amrinone / pharmacology*
Animals
Arterioles / drug effects
Cardiac Output / drug effects*
Cardiotonic Agents / pharmacology*
Dose-Response Relationship, Drug
Milrinone
Pulmonary Wedge Pressure / drug effects*
Pyridones / blood,  pharmacology*
Sheep
Vascular Resistance / drug effects*
Vasodilator Agents / pharmacology*
Chemical
Reg. No./Substance:
0/Cardiotonic Agents; 0/Pyridones; 0/Vasodilator Agents; 60719-84-8/Amrinone; 78415-72-2/Milrinone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fat-free mass and total body water of infants estimated from total body electrical conductivity meas...
Next Document:  Arousal from sleep during rapidly developing hypoxemia in lambs.